EcoStruxure for Life Sciences
How to minimize five risks to life sciences facilities
How to minimize five risks to life sciences facilities
Life Sciences companies face major challenges meeting increasing demand and ensuring regulatory compliance standards, while achieving their cost control goals. Production facilities are closely supervised by national regulators who oblige companies to conform to applicable GMP, (Good Manufacturing Processes). Since GMP procedures involve taking proactive steps to ensure quality and compliance in everything they do, drug manufacturers must accelerate the adoption of innovative technologies to address today’s business challenges and bring transformational changes to the way the lifecycle of medicinal products are managed.
Commentary
‘Tokenmaxxing’ – The wrong AI race to run in Singapore
To outsmart modern fraud, we must first know the enemy
Why Singapore SMEs cannot wait for quantum cyber risk to arrive before securing data
Is Singapore's emphasis on long-term security and stability hindering purpose-driven employees?
When Singapore's agentic AI ‘chefs’ arrive, will the kitchen be ready for them?
What Singapore’s app store rules reveal about the future of online trust
Faster hiring alone will not fix construction’s productivity problem
Beyond policy: How Singapore's service sector can win at the frontline
Solving the production problem behind Singapore’s ‘pilot purgatory’
Transformation without disruption: Your Existing ERP is an accelerant to business innovation